Our end-to-end innovation ecosystem allows clients to architect intelligent and resilient solutions for future missions.
We're building value and opportunity by investing in cybersecurity, analytics, digital solutions, engineering and science, and consulting. Our culture of innovation empowers employees as creative thinkers, bringing unparalleled value for our clients and for any problem we try to tackle.
Empower People to Change the World®
Booz Allen Commercial delivers advanced cyber defenses to the Fortune 500 and Global 2000. We are technical practitioners and cyber-focused management consultants with unparalleled experience – we know how cyber attacks happen and how to defend against them.
Learn how we’re driving empowerment, innovation, and resilience to shape our vision for the future through a focus on environmental, social, and governance (ESG) practices that matter most.
Our 29,200 engineers, scientists, software developers, technologists, and consultants live to solve problems that matter. We’re proud of the diversity throughout our organization, from our most junior ranks to our board of directors and leadership team.
While the Federal Government is committed to executing a comprehensive COVID-19 vaccination campaign, the distribution of vaccines falls individually on state and local government support. In our blog series on the vaccine rollout, Booz Allen’s Chief Medical Officer Kevin Vigilante and our health experts examine best practices and lessons learned from across the health landscape, including potential strategies and approaches that could help state and local governments improve vaccination rollouts.
Without a common data architecture during the COVID-19 pandemic, federal agencies have faced unprecedented challenges. Decision making and evaluation during all stages of the pandemic lifecycle require specific, reliable, and timely data not only about infections, but also about human behavior and global supply chain networks.
A common architecture is needed to collect, share, and store data. Without the ability to collect and curate a wide variety of data from around the world, agencies have had to rely on data that is maintained in numerous individual systems and formats, making it difficult to aggregate and analyze information.
Federal agencies should create a common data architecture to consolidate existing data and collect new information relevant to multiple dimensions of the COVID-19 pandemic. The architecture should include data about testing, tracing, surveillance, personal protective equipment (PPE), supply chains, hospital bed management, and vaccinations, to name a few. It would also help health services agencies and communities be more prepared before the next pandemic or other public health threats.
This common architecture would streamline the use of artificial intelligence and data science tools. It would also enable development of customized applications to rapidly simulate situations across all stages of the next pandemic. Such common architectures are similar to those used on mobile phones, where a company sets requirements that enable developers to rapidly construct an algorithm or app that is interoperable on multiple devices.
Where should federal agencies begin the process of building a common data architecture? It starts with stakeholders communicating their needs, developing common data definitions, and identifying ownership for information collection and management. The results of this effort will improve coordination and information exchange between national and regional initiatives, and if there is coordination across governments, at the global level.
During the ongoing pandemic response, achieving this level of efficiency is easier said than done. However, if properly prioritized and supported by appropriate resources, it is achievable using state-of-the-art data science methods. As we look to capture lessons learned to prepare for the next pandemic and other public health crises, building a common data architecture should be high on the priority list.
Want to stay updated on the COVID-19 vaccine rollout? Check out our health innovation insights. And feel free to share this post with those you care about.